HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cherwinski, H. M. Articles by Phillips, J. H. Search for Related Content PubMed PubMed Citation Articles by Cherwinski, H. M. Articles by Phillips, J. H.

The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function¹

DNAX Research Institute, Palo Alto, CA 94304

CD200R is a member of the Ig supergene family that is primarily expressed on myeloid cells. Recent in vivo studies have suggested that CD200R is an inhibitory receptor capable of regulating the activation threshold of inflammatory immune responses. Here we provide definitive evidence that CD200R is expressed on mouse and human mast cells and that engagement of CD200R by agonist Abs or ligand results in a potent inhibition of mast cell degranulation and cytokine secretion responses. CD200R-mediated inhibition of FcRI activation was observed both in vitro and in vivo and did not require the coligation of CD200R to FcRI. Unlike the majority of myeloid inhibitory receptors, CD200R does not contain a phosphatase recruiting inhibitory motif (ITIM); therefore, we conclude that CD200R represents a novel and potent inhibitory receptor that can be targeted in vivo to regulate mast cell-dependent pathologies.

Related articles in The JI:

IN THIS ISSUE

The JI 2005 174: 1139-1141. [Full Text]  

This article has been cited by other articles:

				A. Lyons, E. J. Downer, S. Crotty, Y. M. Nolan, K. H. G. Mills, and M. A. Lynch CD200 Ligand Receptor Interaction Modulates Microglial Activation In Vivo and In Vitro: A Role for IL-4 J. Neurosci., August 1, 2007; 27(31): 8309 - 8313. [Abstract] [Full Text] [PDF]

				R. Feuer Tickling the CD200 Receptor: A Remedy for Those Irritating Macrophages Am. J. Pathol., August 1, 2007; 171(2): 396 - 398. [Full Text] [PDF]

				S. Zhang and J. H. Phillips Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation J. Leukoc. Biol., February 1, 2006; 79(2): 363 - 368. [Abstract] [Full Text] [PDF]

				M. C. Jenmalm, H. Cherwinski, E. P. Bowman, J. H. Phillips, and J. D. Sedgwick Regulation of Myeloid Cell Function through the CD200 Receptor J. Immunol., January 1, 2006; 176(1): 191 - 199. [Abstract] [Full Text] [PDF]

				I. Shiratori, M. Yamaguchi, M. Suzukawa, K. Yamamoto, L. L. Lanier, T. Saito, and H. Arase Down-Regulation of Basophil Function by Human CD200 and Human Herpesvirus-8 CD200 J. Immunol., October 1, 2005; 175(7): 4441 - 4449. [Abstract] [Full Text] [PDF]

				D. Hatherley, H. M. Cherwinski, M. Moshref, and A. N. Barclay Recombinant CD200 Protein Does Not Bind Activating Proteins Closely Related to CD200 Receptor J. Immunol., August 15, 2005; 175(4): 2469 - 2474. [Abstract] [Full Text] [PDF]